--- title: Cedars-Sinai invests in Neolook – first US institutional investor description: Neolook Solutions secures USD 525.000 from Cedars-Sinai Medical Center via Post-Money SAFE at a USD 7.5M valuation cap – the first US institutional investment in Neolook, with a linked Milestone Equity Agreement tied to clinical trial, health economics, and FDA readiness. image: https://www.neolooksolutions.com/hubfs/Neolook%20Logo%20Large%20FC%201160x263.png --- [Skip to content](https://www.neolooksolutions.com/blog/cedars-sinai-medical-center-invests-in-neolook-solutions-first-us-institutional-investor#main-content) ![Neolook_logo_RGB_FCMark-1](https://www.neolooksolutions.com/hs-fs/hubfs/Neolook_logo_RGB_FCMark-1.png?width=200&height=152&name=Neolook_logo_RGB_FCMark-1.png "Neolook_logo_RGB_FCMark-1") Neolook Uniting those who care Digital eyes and ears on the child in intensive care. Always. English - [Nederlands](https://www.neolooksolutions.com/nl/blog/cedars-sinai-medical-center-invests-in-neolook-solutions-first-us-institutional-investor) - [Deutsch](https://www.neolooksolutions.com/de/blog/cedars-sinai-medical-center-invests-in-neolook-solutions-first-us-institutional-investor) - [English](https://www.neolooksolutions.com/blog/cedars-sinai-medical-center-invests-in-neolook-solutions-first-us-institutional-investor) [Contact us](https://www.neolooksolutions.com/contact-us?hsLang=en) [Home](https://www.neolooksolutions.com/?hsLang=en) [Products](https://www.neolooksolutions.com/products?hsLang=en) [Plans](https://www.neolooksolutions.com/plans?hsLang=en) [Enquiry](https://www.neolooksolutions.com/enquiry?hsLang=en) [Media](https://www.neolooksolutions.com/media?hsLang=en) [Blog](https://www.neolooksolutions.com/blog) [About Us](https://www.neolooksolutions.com/about-us?hsLang=en) This is a search field with an auto-suggest feature attached. - There are no suggestions because the search field is empty. 11 November 2025 # Cedars-Sinai invests in Neolook – first US institutional investor [Marco D'Agata](https://www.neolooksolutions.com/blog/author/marco-dagata) Share: [linkedin-in icon](http://www.linkedin.com/shareArticle?mini=true&url=https://www.neolooksolutions.com/blog/cedars-sinai-medical-center-invests-in-neolook-solutions-first-us-institutional-investor) [envelope icon](mailto:?body=https://www.neolooksolutions.com/blog/cedars-sinai-medical-center-invests-in-neolook-solutions-first-us-institutional-investor) Neolook Solutions B.V., the Dutch neonatal digital health company, has secured USD 525.000 from Cedars-Sinai Medical Center (Los Angeles, California) via a Post-Money SAFE at a USD 7,5 million valuation cap. The investment constitutes Neolook Round 3 and makes Cedars-Sinai the first US institutional investor in the company. The commitment is the direct outcome of a structured three-track international expansion programme executed by Neolook across 2024 and 2025. In the Middle East, Neolook was selected as 1 of 6 startups for the Anjal Z Techstars Founder Catalyst programme (Cohort 05) from 264 global applicants, backed by the Abu Dhabi Early Childhood Authority. In Southeast Asia, Neolook activated a market entry track via Invest International, the Dutch government's internationalisation instrument. In the United States, the ScaleNL programme created the institutional pipeline that led directly to the Cedars-Sinai relationship. The investment is structured as a Post-Money SAFE with a 20 % discount and includes a linked Milestone Equity Agreement. The milestone equity component grants Cedars-Sinai additional rights conditional on three deliverables: a clinical trial, a health economic study and a demonstrated FDA readiness pathway. Cedars-Sinai becomes Neolook's first US reference site and a co-development partner on the clinical and regulatory evidence required for US market entry. [Venture](https://www.neolooksolutions.com/blog/tag/venture) ## Related posts [![](https://www.neolooksolutions.com/hs-fs/hubfs/Neolook%20Logo%20Large%20FC%201160x263.png?height=200&name=Neolook%20Logo%20Large%20FC%201160x263.png)](https://www.neolooksolutions.com/blog/neolook-single-source-eu-mdr-position-neolook-one-and-neolook-mira?hsLang=en) [Venture](https://www.neolooksolutions.com/blog/tag/venture) ## [Neolook extends single-source EU MDR position: Neolook One and Mira smart sensorheads](https://www.neolooksolutions.com/blog/neolook-single-source-eu-mdr-position-neolook-one-and-neolook-mira?hsLang=en) [Marco D'Agata](https://www.neolooksolutions.com/blog/author/marco-dagata) 9 March 2026 Neolook achieved MDR CE for both the Neolook One – its high end smart sensorhead with modular... [Read more](https://www.neolooksolutions.com/blog/neolook-single-source-eu-mdr-position-neolook-one-and-neolook-mira?hsLang=en) [![](https://www.neolooksolutions.com/hs-fs/hubfs/Neolook%20Logo%20Large%20FC%201160x263.png?height=200&name=Neolook%20Logo%20Large%20FC%201160x263.png)](https://www.neolooksolutions.com/blog/cry-detection-ai-1.0-clears-first-clinical-acceptance-gate-at-radboudumc-nijmegen?hsLang=en) [Venture](https://www.neolooksolutions.com/blog/tag/venture) ## [Cry Detection AI 1.0 clears first clinical acceptance gate at Radboudumc – Nijmegen](https://www.neolooksolutions.com/blog/cry-detection-ai-1.0-clears-first-clinical-acceptance-gate-at-radboudumc-nijmegen?hsLang=en) [Marco D'Agata](https://www.neolooksolutions.com/blog/author/marco-dagata) 9 December 2022 In August 2022, Neolook's Cry Detection 1.0 prototype passed a formal acceptance-test protocol at... [Read more](https://www.neolooksolutions.com/blog/cry-detection-ai-1.0-clears-first-clinical-acceptance-gate-at-radboudumc-nijmegen?hsLang=en) [![](https://www.neolooksolutions.com/hs-fs/hubfs/Neolook3winspicture.png?height=200&name=Neolook3winspicture.png)](https://www.neolooksolutions.com/blog/news/neolook-wins-3-international-growth-programs?hsLang=en) [Achievement](https://www.neolooksolutions.com/blog/tag/achievement) ## [3 Growth Programs for USA, MI and EU](https://www.neolooksolutions.com/blog/news/neolook-wins-3-international-growth-programs?hsLang=en) [Marco D'Agata](https://www.neolooksolutions.com/blog/author/marco-dagata) 2 October 2024 Born in 2020, after four yours of dedicated work-work-work, we are happily surprised by being noted... [Read more](https://www.neolooksolutions.com/blog/news/neolook-wins-3-international-growth-programs?hsLang=en) #### Our Services - [Home](https://www.neolooksolutions.com) - [Products](https://www.neolooksolutions.com/products) - [Plans](https://www.neolooksolutions.com/plans) - [Media](https://www.neolooksolutions.com/media) - [Blog](https://www.neolooksolutions.com/blog) #### Get In Touch - [Contact](https://www.neolooksolutions.com/contact-us) - [Enquiries](https://www.neolooksolutions.com/enquiry) - [Investors](https://www.neolooksolutions.com/investors) #### Regulatory - [Code of Conduct](https://www.neolooksolutions.com/cookie-statement) - [Terms and Conditions](https://www.neolooksolutions.com/terms-and-conditions) - [Privacy Statement](https://www.neolooksolutions.com/privacy-statement) - [Cookie Statement](https://www.neolooksolutions.com/cookie-statement) - [Disclaimer](https://www.neolooksolutions.com/disclaimer) Neolook Solutions BV Princetonlaan 6, 3584 CB Utrecht The Netherlands Chamber of Commerce 77050797      Copyright © 2020-2026, Neolook Solutions ```json { "@context" : "https://schema.org", "@type" : "BlogPosting", "author" : { "@type" : "Person", "name" : "Marco D'Agata", "url" : "https://www.neolooksolutions.com/blog/author/marco-dagata" }, "dateModified" : "2026-04-25T06:27:27.232Z", "datePublished" : "2025-11-11T10:00:00.000Z", "headline" : "Cedars-Sinai invests in Neolook – first US institutional investor", "image" : [ "https://www.neolooksolutions.com/hubfs/Neolook%20Logo%20Large%20FC%201160x263.png" ], "mainEntityOfPage" : { "@id" : "https://www.neolooksolutions.com/blog/cedars-sinai-medical-center-invests-in-neolook-solutions-first-us-institutional-investor", "@type" : "WebPage" }, "publisher" : { "@type" : "Organization", "logo" : { "@type" : "ImageObject", "url" : "https://www.neolooksolutions.com/hubfs/Neolook_logo_RGB_FCMark-1.png" }, "name" : "Neolook Solutions" } } ```